These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 17284086)

  • 1. The clinical applications of fluorouracil in ophthalmic practice.
    Abraham LM; Selva D; Casson R; Leibovitch I
    Drugs; 2007; 67(2):237-55. PubMed ID: 17284086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical chemotherapy for giant ocular surface squamous neoplasia of the conjunctiva and cornea: Is surgery necessary?
    Chaugule SS; Park J; Finger PT
    Indian J Ophthalmol; 2018 Jan; 66(1):55-60. PubMed ID: 29283124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical fluorouracil after surgery for ocular surface squamous neoplasia in Kenya: a randomised, double-blind, placebo-controlled trial.
    Gichuhi S; Macharia E; Kabiru J; Zindamoyen AM; Rono H; Ollando E; Wachira J; Munene R; Maina J; Onyuma T; Sagoo MS; Weiss HA; Burton MJ
    Lancet Glob Health; 2016 Jun; 4(6):e378-85. PubMed ID: 27198842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pulse-dose topical 1% 5-fluorouracil treatment regimen in a young dog with corneal squamous cell carcinoma.
    Overton TL; Allbaugh RA; Whitley D; Ben-Shlomo G; Griggs A; Tofflemire KL; Whitley EM
    Vet Ophthalmol; 2015 Jul; 18(4):350-4. PubMed ID: 25270617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [5-fluorouracil in the treatment of postoperative glaucoma].
    Kuljaca Z; Jojić Z
    Srp Arh Celok Lek; 1996; 124(7-8):190-2. PubMed ID: 9102845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical 5-fluorouracil for the treatment of periocular actinic keratosis and low-grade squamous malignancy.
    Couch SM; Custer PL
    Ophthalmic Plast Reconstr Surg; 2012; 28(3):181-3. PubMed ID: 22460673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant 5-fluorouracil in the treatment of localised ocular surface squamous neoplasia.
    Rudkin AK; Muecke JS
    Br J Ophthalmol; 2011 Jul; 95(7):947-50. PubMed ID: 21252085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical chemotherapy for ocular surface squamous neoplasia: current status.
    Sepulveda R; Pe'er J; Midena E; Seregard S; Dua HS; Singh AD
    Br J Ophthalmol; 2010 May; 94(5):532-5. PubMed ID: 19776089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunosuppression as a Possible Risk Factor for Interferon Nonresponse in Ocular Surface Squamous Neoplasia.
    Ashkenazy N; Karp CL; Wang G; Acosta CM; Galor A
    Cornea; 2017 Apr; 36(4):506-510. PubMed ID: 28129301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical 1% 5-fluoruracil as a sole treatment of corneoconjunctival ocular surface squamous neoplasia: long-term study.
    Parrozzani R; Frizziero L; Trainiti S; Testi I; Miglionico G; Pilotto E; Blandamura S; Fassina A; Midena E
    Br J Ophthalmol; 2017 Aug; 101(8):1094-1099. PubMed ID: 27941046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolution of 5-fluorouracil-based chemoradiation in the management of rectal cancer.
    Patel PA
    Anticancer Drugs; 2011 Apr; 22(4):311-6. PubMed ID: 21301320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of dihydropyrimidine dehydrogenase expression in resistance to 5-fluorouracil in head and neck squamous cell carcinoma cells.
    Yasumatsu R; Nakashima T; Uryu H; Masuda M; Hirakawa N; Shiratsuchi H; Tomita K; Fukushima M; Komune S
    Oral Oncol; 2009 Feb; 45(2):141-7. PubMed ID: 18620897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-Term Efficacy and Safety of Subconjunctival/Perilesional 5-Fluorouracil Injections for Ocular Surface Squamous Neoplasia.
    Sun Y; Hua R
    Drug Des Devel Ther; 2020; 14():5659-5665. PubMed ID: 33376309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of 5-Fluorouracil derivatives as anticancer agents.
    Pan X; Wang C; Wang F; Li P; Hu Z; Shan Y; Zhang J
    Curr Med Chem; 2011; 18(29):4538-56. PubMed ID: 21864282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitomycin: clinical applications in ophthalmic practice.
    Abraham LM; Selva D; Casson R; Leibovitch I
    Drugs; 2006; 66(3):321-40. PubMed ID: 16526821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subconjunctival sustained release 5-fluorouracil for glaucoma filtration surgery.
    Cui LJ; Sun NX; Li XH; Huang J; Yang JG
    Acta Pharmacol Sin; 2008 Sep; 29(9):1021-8. PubMed ID: 18718170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-fluorouracil and dihydropyrimidine dehydrogenase.
    Kubota T
    Int J Clin Oncol; 2003 Jun; 8(3):127-31. PubMed ID: 12851835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Capecitabine in gastric cancer.
    Okines A; Chau I; Cunningham D
    Drugs Today (Barc); 2008 Aug; 44(8):629-40. PubMed ID: 18846273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethogel topical formulation for increasing the local bioavailability of 5-fluorouracil: a mechanistic study.
    Puri R; Jain S
    Anticancer Drugs; 2012 Oct; 23(9):923-34. PubMed ID: 22926258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility of measuring 5-fluorouracil catabolic potential by oral loading.
    Watabe S; Sengoku H; Kawai K; Matsuda M; Sakamoto K; Kamano T
    J Int Med Res; 2005; 33(5):501-6. PubMed ID: 16222882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.